Industry Partners

Run your clinical research trial with us

With many years of experience running clinical trials, and as the industry leader in Alzheimer’s research, we have both the resources and clinical capabilities to ensure your trials run on time and within budget.

Call Now: (571) 591-3380

"*" indicates required fields

Contact Us

Name*

First Last

Email Address*

Company Name*

This field is for validation purposes and should be left unchanged.

Explore the page

Benefits with Us
Our Team
Trials
Our Centers
Blog
Sign Up

What We Do At Recognition Health

We specialize in delivering clinical trials in the field of neurodegenerative diseases with a particular focus on Alzheimer’s disease.

WHY WORK WITH RE:COGNITION HEALTH?

Rapid set-up and scalable with a dedicated team with Clinical Trial Agreement and Budget review within 2 weeks
Multiple US locations and a diverse patient population
Centralized contract and budget negotiation to streamline the process
Clinical Trial Agreement and Budget review within 2 weeks (further acceleration can be requested)
Length of studies available, from 6 weeks to 3 years and more
A qualified team comprising of international and multi-lingual doctors in a variety of roles

Our Principal Investigators

Our doctors provide you with patient-first care through expert neurology, psychology, and psychiatry assessments and treatments.

Dr. Scott Turner

Principal Investigator
Dr. Claudia Perez

Principal Investigator

Trials

AACQ, TRAILBLAZER-ALZ 6

Sponsor

Total Treatment Duration

76 Weeks

Patients Screened

78

Patients Enrolled

32

Randomization Rate

41%

Sponsor

Eli Lilly Clinical Trials
TB006, TrueBinding

Sponsor

Total Treatment Duration

104 Days

Patients Screened

38

Patients Enrolled

14

Randomization Rate

39%

Sponsor

TrueBinding Inc.
PTl-125-07, Cassava

Sponsor

Total Treatment Duration

54 Weeks

Patients Screened

138

Patients Enrolled

39

Randomization Rate

21%

Sponsor

Cassava Sciences Inc.
LAKC, TRAILBLAZER-ALZ 1

Sponsor

Total Treatment Duration

36 Weeks

Patients Screened

179

Patients Enrolled

34

Randomization Rate

19%

Sponsor

Eli Lilly Clinical Trials
251AD201, Biogen

Sponsor

Total Treatment Duration

78 Weeks

Patients Screened

69

Patients Enrolled

12

Randomization Rate

17%

Sponsor

Biogen Inc.
CuraSen CLIN-015

Sponsor

Total Treatment Duration

4 Weeks

Sponsor

CuraSen Therapeutics

GCSA Certification in the US and Europe

Re:Cognition Health Becomes the First Organization to Earn Internationally Recognized GCSA Certification in both the US and Europe. The GCSA Certification is a hallmark of quality in clinical research, awarded only to sites that demonstrate adherence to global best-practice standards. This certification was granted following a rigorous assessment conducted by the GCSA Assessment Team at the International Accrediting Organization for Clinical Research (IAOCR).

Learn More

Our UK and USA centers are proud to be part
of the PPD Select Partnership Programme.

The Re:Cognition Health UK and US site networks are proud to be preferred sites within the PPD Select Partnership Program of Thermo Fisher Scientific’s PPD clinical research business, a global leader in clinical research. We’re excited about the opportunities this relationship brings, and we are looking forward to working with the PPD Strategic Site Collaborations team and evolving our relationship within the PPD Select Program, across our existing ten sites.

Our Centers

Come visit our centers

Our centers located throughout the US are set up for your comfort with experts and consultants to walk you through the trial process.